DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Central Nervous System Partnering 2010-2017: Deal trends, players and financials" report to their offering.
Global Central Nervous System Partnering 2010 to 2017 provides the full collection of Central Nervous System disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Central Nervous System disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Central Nervous System deals.
- Trends in Central Nervous System dealmaking in the biopharma industry since 2010
- Analysis of Central Nervous System deal structure
- Access to headline, upfront, milestone and royalty data
- Access to hundreds of Central Nervous System deal contract documents
- Comprehensive access to over 3500 Central Nervous System deal records
- The leading Central Nervous System deals by value since 2010
- Most active Central Nervous System dealmakers since 2010
In Global Central Nervous System Partnering 2010 to 2017, available deals and contracts are listed by:
- Headline value
- Upfront payment value
- Royalty rate value
- Stage of development at signing
- Deal component type
- Technology type
- Specific therapy indication
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in Central Nervous System dealmaking
Chapter 3 - Financial deal terms for Central Nervous System partnering
Chapter 4 - Leading Central Nervous System deals and dealmakers
Chapter 5 - Central Nervous System contract document directory
Chapter 6 - Central Nervous System dealmaking by therapeutic target
For more information about this report visit http://www.researchandmarkets.com/research/b9sj24/global_central